The expression of MTAP in prostate cancer and its effect on immune cells

Qin Zizhen; Liu Qingyuan; Wu Yuqi; Su Shuai; Zhang Jindong; Li Yue; Wang Delin

doi:10.13406/j.cnki.cyxb.003429

您当前的位置：

首页 >

文章列表页 >

The expression of MTAP in prostate cancer and its effect on immune cells

Clinical research | 更新时间：2025-10-22

- The expression of MTAP in prostate cancer and its effect on immune cells
- Journal of Chongqing Medical University Vol. 49, Issue 2, Pages: 222-230(2024)
- 作者机构：
  
  1.重庆医科大学附属第一医院泌尿外科,重庆 400016
  2.深圳大学附属华南医院泌尿外科,深圳 518055
  3.重庆医科大学分子医学与肿瘤研究中心,重庆 400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003429
  CLC： R737.25
- Received：15 October 2023，
  
  Revised：2023-11-23，
  
  Accepted：28 November 2023，
  
  Published：28 February 2024
- 稿件说明：
移动端阅览
秦梓榛,刘清源,武雨琦,等.MTAP在前列腺癌中的表达及对免疫细胞的影响初探[J].重庆医科大学学报,2024,49(2):222-230.

Qin Zizhen,Liu Qingyuan,Wu Yuqi,et al.The expression of MTAP in prostate cancer and its effect on immune cells[J].Journal of Chongqing Medical University,2024,49(2):222-230.
秦梓榛,刘清源,武雨琦,等.MTAP在前列腺癌中的表达及对免疫细胞的影响初探[J].重庆医科大学学报,2024,49(2):222-230. DOI： 10.13406/j.cnki.cyxb.003429.

Qin Zizhen,Liu Qingyuan,Wu Yuqi,et al.The expression of MTAP in prostate cancer and its effect on immune cells[J].Journal of Chongqing Medical University,2024,49(2):222-230. DOI： 10.13406/j.cnki.cyxb.003429.

摘要

目的

探究甲硫腺苷磷酸化酶（methylthioadenosine phosphorylase，MTAP）在前列腺癌不同临床阶段的表达差异及其对免疫细胞的影响。

方法

从TCGA和GTEx数据库中获取MTAP的表达谱数据，利用生物信息学方法进行泛癌分析。免疫组化验证上述结论并探究MTAP与临床病理指标之间的关联。RT-qPCR和Western blot检测MTAP在不同前列腺癌细胞系中的表达水平，分析MTAP与肿瘤恶性程度之间的关联。生物信息学方法分析前列腺癌中MTAP与免疫细胞的关联并进行免疫组化验证。

结果

在前列腺癌中，MTAP的表达在肿瘤发生早期升高后逐渐降低，与T分期和Gleason评分呈负相关（

=-0.576，

=0.000，

=-0.284，

=0.020）。MTAP与多种免疫细胞存在相关关系，其中MTAP与CD4

T细胞呈正相关（

=0.643，

=0.000），与NK CD56

bright

细胞呈负相关（

=-0.570，

=0.000）。

结论

前列腺癌中，MTAP的表达呈现早期升高后逐渐下降的趋势，与T分期和Gleason评分呈负相关。MTAP对免疫细胞的浸润和细胞功能的发挥有调节作用，是一种潜在的生物学标志物和免疫治疗靶点。

Abstract

Objective

To explore the expression of Methylthioadenosine phosphorylase（MTAP） in different clinical stages of prostate cancer and its correlation with immune cells.

Methods

The expression profile of MTAP was obtained from TCGA and GTEx databases，and pancarcinoma was analyzed by bioinformatics method. Immunohistochemistry verified the conclusions above and explored the correlation between MTAP and clinicopathological features. The expression levels of MTAP in different prostate cancer cell lines were detected by RT-qPCR and Western blot，and the correlation between MTAP and the degree of malignancy was analyzed. The correlatoin between MTAP and immune cells in prostate cancer was analyzed by bioinformatics and verified by immunohistochemistry.

Results

In prostate cancer，the expression of MTAP increased at early stage and then decreased gradually，and was negatively correlated with T stage and Gleason score（

=-0.576，

=0.000，

=-0.284，

=0.020）. MTAP was correlated with a variety of immune cells，among which MTAP was positively correlated with CD4

T cells（

=0.643，

=0.000），was significantly negatively correlated with NK CD56

bright

cells（

=-0.570，

=0.000）.

Conclusion

In prostate cancer，the expression of MTAP increased at the early stage and then decreased gradually，which was negatively correlated with T stage and Gleason score. MTAP can regulate the infiltration and function of immune cells，and is a potential biomarker and immunotherapy target.

关键词

Keywords

references

Sung H ， Ferlay J ， Siegel RL ， et al . Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin ， 2021 ， 71 （ 3 ）： 209 - 249 ．

Li J ， Xu CL ， Lee HJ ， et al . A genomic and epigenomic atlas of prostate cancer in Asian populations [J ] . Nature ， 2020 ， 580 （ 7801 ）： 93 - 99 ．

Huggins C ， Hodges CV . Studies on prostatic cancer：I. The effect of castration，of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941 [J ] . J Urol ， 2002 ， 168 （ 1 ）： 9 - 12 ．

Crawford ED ， Higano CS ， Shore ND ， et al . Treating patients with metastatic castration resistant prostate cancer：a comprehensive review of available therapies [J ] . J Urol ， 2015 ， 194 （ 6 ）： 1537 - 1547 ．

James ND ， Sydes MR ， Clarke NW ， et al . Addition of docetaxel，zoledronic acid，or both to first-line long-term hormone therapy in prostate cancer （STAMPEDE）：survival results from an adaptive，multiarm，multistage，platform randomised controlled trial [J ] . Lancet ， 2016 ， 387 （ 10024 ）： 1163 - 1177 ．

Topalian SL ， Hodi FS ， Brahmer JR ， et al . Safety，activity，and immune correlates of anti-PD-1 antibody in cancer [J ] . N Engl J Med ， 2012 ， 366 （ 26 ）： 2443 - 2454 ．

Nobori T ， Takabayashi K ， Tran P ， et al . Genomic cloning of methylthioadenosine phosphorylase：a purine metabolic enzyme deficient in multiple different cancers [J ] . Proc Natl Acad Sci U S A ， 1996 ， 93 （ 12 ）： 6203 - 6208 ．

Lubin M ， Lubin A . Selective killing of tumors deficient in methylthioadenosine phosphorylase：a novel strategy [J ] . PLoS One ， 2009 ， 4 （ 5 ）： e5735 ．

Williams-Ashman HG ， Seidenfeld J ， Galletti P . Trends in the biochemical pharmacology of 5'-deoxy-5'-methylthioadenosine [J ] . Biochem Pharmacol ， 1982 ， 31 （ 3 ）： 277 - 288 ．

Christopher SA ， Diegelman P ， Porter CW ， et al . Methylthioadenosine phosphorylase，a gene frequently codeleted with p16（cdkN2a/ARF），acts as a tumor suppressor in a breast cancer cell line [J ] . Cancer Res ， 2002 ， 62 （ 22 ）： 6639 - 6644 ．

Hustinx SR ， Hruban RH ， Leoni LM ， et al . Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer：a potential new target for therapy [J ] . Cancer Biol Ther ， 2005 ， 4 （ 1 ）： 83 - 86 ．

Su CY ， Chang YC ， Chan YC ， et al . MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients [J ] . Eur J Surg Oncol ， 2014 ， 40 （ 9 ）： 1143 - 1150 ．

Affronti HC ， Rowsam AM ， Pellerite AJ ， et al . Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy [J ] . Nat Commun ， 2020 ， 11 （ 1 ）： 52 ．

Montironi R ， Cimadamore A ， Lopez-Beltran A ， et al . Morphologic，molecular and clinical features of aggressive variant prostate cancer [J ] . Cells ， 2020 ， 9 （ 5 ）： 1073 ．

Wu YQ ， Liu XB ， Qin ZZ ， et al . Low-frequency ultrasound enhances chemotherapy sensitivity and induces autophagy in PTX-resistant PC-3 cells via the endoplasmic reticulum stress-mediated PI3K/Akt/mTOR signaling pathway [J ] . Onco Targets Ther ， 2018 ， 11 ： 5621 - 5630 ．

Humphrey PA . Histopathology of prostate cancer [J ] . Cold Spring Harb Perspect Med ， 2017 ， 7 （ 10 ）： a030411 ．

Namekawa T ， Ikeda K ， Horie-Inoue K ， et al . Application of prostate cancer models for preclinical study：advantages and limitations of cell lines，patient-derived xenografts，and three-dimensional culture of patient-derived cells [J ] . Cells ， 2019 ， 8 （ 1 ）： 74 ．

Bertino JR ， Waud WR ， Parker WB ， et al . Targeting tumors that lack methylthioadenosine phosphorylase （MTAP） activity：current strategies [J ] . Cancer Biol Ther ， 2011 ， 11 （ 7 ）： 627 - 632 ．

Marcé S ， Balagué O ， Colomo L ， et al . Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival：implications for a potential targeted therapy [J ] . Clin Cancer Res ， 2006 ， 12 （ 12 ）： 3754 - 3761 ．

Krasinskas AM ， Bartlett DL ， Cieply K ， et al . CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival [J ] . Mod Pathol ， 2010 ， 23 （ 4 ）： 531 - 538 ．

Huang HY ， Li SH ， Yu SC ， et al . Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors [J ] . Clin Cancer Res ， 2009 ， 15 （ 22 ）： 6963 - 6972 ．

Collins CC ， Volik SV ， Lapuk AV ， et al . Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase，an exploitable tumor target [J ] . Mol Cancer Ther ， 2012 ， 11 （ 3 ）： 775 - 783 ．

Williams-Ashman HG ， Canellakis ZN . Polyamines in mammalian biology and medicine [J ] . Perspect Biol Med ， 1979 ， 22 （ 3 ）： 421 - 453 ．

Harrison GA . The approximate determination of spermine in single human organs [J ] . Biochem J ， 1933 ， 27 （ 4 ）： 1152 - 1156 ．

Pegg AE ， Lockwood DH ， Williams-Ashman HG . Concentrations of putrescine and polyamines and their enzymic synthesis during androgen-induced prostatic growth [J ] . Biochem J ， 1970 ， 117 （ 1 ）： 17 - 31 ．

Kirovski G ， Stevens AP ， Czech B ， et al . Down-regulation of methylthioadenosine phosphorylase （MTAP） induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine （MTA） [J ] . Am J Pathol ， 2011 ， 178 （ 3 ）： 1145 - 1152 ．

顾伟杰，朱　耀 . 2022版《CSCO前列腺癌诊疗指南》更新要点解读 [J ] . 中国肿瘤外科杂志， 2022 ， 14 （ 3 ）： 224 - 232 ．

Gu WJ ， Zhu Y . Update and interpretation of the 2022 guidelines for the diagnosis and treatment of prostate cancer by Chinese society of clinical oncology （CSCO） [J ] . Chin J Surg Oncol ， 2022 ， 14 （ 3 ）： 224 - 232 ．

Havel JJ ， Chowell D ， Chan TA . The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy [J ] . Nat Rev Cancer ， 2019 ， 19 （ 3 ）： 133 - 150 ．

Kruger S ， Ilmer M ， Kobold S ， et al . Advances in cancer immunotherapy 2019-latest trends [J ] . J Exp Clin Cancer Res ， 2019 ， 38 （ 1 ）： 268 ．

Henrich FC ， Singer K ， Poller K ， et al . Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cells [J ] . Oncoimmunology ， 2016 ， 5 （ 8 ）： e1184802 ．

Poli A ， Michel T ， Thérésine M ， et al . CD56bright natural killer （NK） cells：an important NK cell subset [J ] . Immunology ， 2009 ， 126 （ 4 ）： 458 - 465 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Association of miR-296-5p，S-phase kinase-associated protein 2， and ribosomal protein L6 with the pathological features of prostate cancer and their influence on surgical prognosis

Screening for feature genes and immune infiltration of multiple myeloma: a study based on support vector machine

Anti-tumor effect and prognostic value of ubiquitin-specific protease 53 in colorectal cancer

Deleted in liver cancer-1 inhibits the proliferation and invasion of enzalutamide-resistant prostate cancer cells via the Rho pathway

Application of nanoparticles in the treatment of prostate cancer

Related Author

Liu Jiaxin

Zhang Canfeng

Yang Wenbo

Shi Lei

Zhang Hongbin

You Shuyun

Wang Xuelian

Su Linjie

Related Institution

Critical Care Medicine 1st Ward, Xinxiang Central Hospital，The Fourth Clinical College of Xinxiang Medical College

Urology 2nd Ward, Xinxiang Central Hospital，The Fourth Clinical College of Xinxiang Medical College

Department of Hematology，The First Affiliated Hospital of Chongqing Medical University

Department of Cardiology，The First Affiliated Hospital of Chongqing Medical University

Department of Oncology，The First Affiliated Hospital of Chongqing Medical University

⁰